Skip to content

Clinical trials

Phase 2 Hemochromatosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemochromatosis Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20071
20131
20141
20151
20171
20181
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Rennes University Hospital2
CSL Behring1
Haukeland University Hospital1
La Jolla Pharmaceutical Company1
Lipomed1
National Heart, Lung, and Blood Institute (NHLBI)1
National Institutes of Health Clinical Center (CC)1
Protagonist Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemochromatosis11
Iron Overload7
Thalassemia3
Myelodysplastic Syndromes2
Anemia1
Anemia, Diamond-Blackfan1
Anemia, Sideroblastic1
Disease1
Hematologic Diseases1
Hemoglobinopathies1

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.